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Although evidence supports the function of telomere length (TL) as a marker for biological aging, no major
determinants of TL are known besides inheritance, age and gender. Here we validate and, more importantly,
assess the impact of paternal age at birth as a determinant for the offspring’s peripheral blood leukocyte TL
within the Asklepios study population. Telomere restriction fragment length and paternal age information
were available for 2433 volunteers (1176 men and 1257 women) aged ~35–55 years old. Paternal age at
birth was positively associated with offspring TL (offspring age and gender adjusted, P < 10 (214)). The
increase in TL was estimated at 17 base pairs for each supplemental year at birth and was not statistically
different between male and female offspring. The effect size of paternal age outweighed the classical
TL determinant gender by a factor of 2, demonstrating the large impact. Maternal age at birth was not inde-
pendently associated with offspring TL. The peculiar interaction between paternal age at birth and inheri-
tance might explain a large part of the genetic component of TL variance on a population level. This
finding also provides further proof for the theory that TL is not completely reset in the zygote.
Furthermore, as paternal age is subject to demographic evolution, its association with TL might have a sub-
stantial impact on the results and comparability of TL within and between epidemiological studies. In con-
clusion, paternal age is an important determinant for TL, with substantial consequences for future studies.
INTRODUCTION
Mammalian telomeres, located at the ends of the chromo-
somes, consist of non-coding TTAGGG repeats protected
within a higher order nucleoprotein complex. With each cell
division, the most distal telomere repeats are lost as a result
of the end-replication problem, a process that is accelerated
by environmental conditions like oxidative stress. Uncompen-
sated, this will ultimately lead to a critical telomere shortening
which in turn triggers replicative senescence and proliferation
arrest at a cellular level as observed in vitro. Telomeres are
therefore considered to act as a mitotic clock. The most
common mechanism to avoid this putative tumor suppression
mechanism is the activation of telomerase, an RNA-dependent
telomere elongating enzyme (1–3).
On a population level, only few determinants of telomere
length (TL) are currently known. General heritability is pro-
posed to be the major mechanism explaining interindividual
TL variation (4–7). Both X-linked and paternal inheritance
have been suggested (8–10) and several putative TL affecting
loci have been reported (11,12). Telomere shortening during
cell division is reflected in an age-dependent telomere attrition
at the systemic level, providing a second main cause of variation
between subjects. While there is no significant gender-
dependent difference in TL at birth, further in lifetime telomeres
are shorter in men as compared with women presumably due to
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a higher age-dependent telomere attrition rate in the former,
providing a third important source of variation (13–18).
Cross-sectional studies have shown TL to be further modu-
lated by other factors, such as oxidative stress, inflammation,
life stress and unhealthy lifestyle (19–23), and even demon-
strate shorter TL to be associated with an increased risk for
cardiovascular disease (23–26). Although these and other
findings support a biological aging biomarker value for TL,
they only explain a small fraction of TL variance.
In a population of 125 subjects, Unryn et al. (17) showed
that TL of children is correlated with paternal age at birth.
This association was found to be borderline significant in a
larger population of .900 Amish individuals (10). Here we
validate this association and assess its impact in the large Ask-
lepios study population. This study was designed as a longi-
tudinal study, with the first round completed in 2004. A total
of 2524 Caucasian volunteers free of overt cardiovascular
disease and aged ~35–55 years were enrolled in the study
which aims at a better understanding of cardiovascular
disease and aging dependent processes (27).
RESULTS
The baseline characteristics for the population under study
have been summarized in Table 1. As described previously
(22), TL was negatively correlated with age (P , 10 (225)).
Although based on cross-sectional data, the decrease in TL
appears significantly faster in men as compared with women,
as can be seen in a General Linear Model (GLM) containing
both age, gender as factor and the interaction term age–
gender: the interaction term was significant, P ¼ 0.033, while
gender as a factor, P ¼ 0.163, was not. This resulted in a
shorter TL in men compared with women (GLM without inter-
action term, P, 10 (27)). The association between TL and
age for both men and women is depicted in Figure 1.
Paternal age showed a substantial positive linear correlation
with TL (R ¼ 0.127, P, 10 (29)). In order to estimate the
influence of paternal age on TL in a population, two GLMs
were constructed which adjusted for offspring age and
gender. In the first model, gender was considered as a
factor, while the second also contained a gender– offspring
age interaction term reflecting the difference in TL dynamics
between both genders (Tables 2 and 3). These tables clearly
show that, among the variables under study, offspring age
was the most important variable explaining interindividual TL
variance. Paternal age at birth was however unambiguously
the second most important determinant, with an effect size
outweighing the gender component by a factor of 2
(Table 2). After adjustment for paternal age, the cross section-
ally estimated telomere attrition still appeared to be signifi-
cantly faster in men compared with women (interaction
term, P ¼ 0.040). The effect of paternal age on the children’s
TL is depicted in Figure 2. Both GLMs explain ~8% of total
TL variability. Adding or replacing paternal age with
squared, cubic, root or logarithmic paternal age terms did
not significantly improve the fit of the GLM.
Maternal age at birth could be provided by all women and
all but five men, and was significantly associated with TL in
both models adjusting for age and gender (both P,
10(29)). However, this observation might be explained by
the strong correlation between maternal and paternal age at
birth (R ¼ 0.842, P-value under limit). This becomes apparent
after stratification of the population into paternal age or
maternal age quartiles. Maternal age was no longer signifi-
cantly associated with TL in each of the paternal age quartiles
(age and gender adjusting GLMs, P . 0.220 for each quartile),
while paternal age remained significantly associated with TL
in each of the maternal age quartiles (age and gender adjusting
GLMs, P , 0.026 for each quartile). This shows that, most
likely, only paternal age is a determinant for TL. The same
conclusions were drawn irrespective of the manner in which
the models adjusted for gender.
After splitting the dataset according to gender, in men, (off-
spring age-adjusted) TL values are estimated to increase with
15.5 bp (95% CI: 9.6–21.3) for each year the father is older at
their sons’ birth. For daughters, this estimate is 19.1 bp (95%
CI: 13.0–25.3), showing no statistical difference between both
genders. This clearly shows that TL is longer in children from
older fathers, irrespective of the offspring’s gender. This can
be graphically confirmed by comparing the effects of gender
on, respectively, TL versus age and TL versus paternal age
(Figs 1 and 2). The slope is significantly different between
men and women for TL as a function of subject’s age, but
not for paternal age.
Without adjustment for paternal age, the cross sectionally
estimated telomere attrition rates for the 2433 men and
women were, respectively, 31.0 and 20.7 bp/year (Fig. 1).
After inclusion of paternal age in the models these estimates
increase to, respectively, 32.9 and 23.6 bp/year. These
increases can be explained by a demographic shift in the Ask-
lepios study population, with younger parents for younger
study participants. This is demonstrated by the positive,
linear correlation between paternal age and offspring age
(R ¼ 0.125, P , 10(29)). Lack of adjustment for paternal
age therefore results in an underestimate of the telomere attri-
tion rates. The impact of this finding is further elaborated in
the Discussion section.
DISCUSSION
In this report, we provide clear evidence that paternal age at
birth is an important TL determinant, even more important
than gender. In the Asklepios study population, age, paternal
age and gender explain ~8% of total TL variability. Since
the age-range of the Asklepios cohort is rather narrow, ~20
Table 1. Baseline characteristics reported subset Asklepios population
Men Women P-valuea All
Mean SD Mean SD Mean SD
Age (years) 46.2 5.9 45.9 6.0 0.175 46.0 6.0
TL (kbp) 7.79 0.72 7.96 0.73 1  10 (28) 7.88 0.73
Paternal age (years) 31.8 6.7 31.5 6.5 0.394 31.7 6.6
Maternal age (years) 29.4 6.1 29.3 5.9 0.651 29.3 6.0
aSignificance of difference between men and women (t-test).
kbp, kilo base-pairs.
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years, this fraction should be larger for the total population,
explaining a substantial part of TL variability next to the
inherited component.
Since paternal but not maternal age at birth appears to be
directly associated with TL, the cause of the observed effect
is almost certainly the influence of paternal age at conception.
One might hypothesize that paternal age at conception could
modulate the offspring age-dependent telomere attrition rate
instead of influencing baseline TL at birth. This is however
very unlikely since, although based on cross-sectional
results, the paternal age–offspring age interaction term was
clearly not significant when added to the models (both
models, P. 0.270).
TL has been shown to increase in human sperm cells with the
age of the donor (28), almost certainly due to the constitutive
telomerase activity present in adult testis (29). Current evi-
dence shows that TL is to a certain extent inherited allele
specifically (7), and that extensive TL variation, existing in
the male germline (30), is partially maintained throughout
development (31), suggesting that TL variability is at least to
a certain extent maintained in the zygote. This provides a
probable explanation for the association between TL and
paternal age at birth: the prolonged exposure to constitutive tel-
omerase activity in the testis results in longer telomeres in the
sperm cells of older fathers, which, after not being completely
reset in the zygote, is manifested in the longer offspring TL.
We found that for each year the father is older, at birth the
child has on average 17 bp longer telomeres. This is lower
Figure 1. Telomere lengths for different ages with a faster decline in men (filled squares, M) than in women (open circles, F).
Table 2. GLM with gender as factor and TL as dependent variable (R2 ¼
0.081)
Estimate Unit 95% CI P-value Effect sizea
Intercept 8529 bp 8.285 to 8.773 UDL 0.659
Offspring age 228 bp/year 223 to 233 1  10 (230) 0.053
Genderb 163 bp 107 to 219 1  10 (28) 0.013
Paternal age 17 bp/year 13 to 22 2  10 (215) 0.026
aPartial eta squared values.
bAmount by which TL is larger in women compared with men.
CI, confidence interval; UDL, under detection limit.
Table 3. GLM with gender–offspring interaction term and TL as dependent
variable (R2 ¼ 0.082)
Estimate Unit 95% CI P-value Effect sizea
Intercept 8616 bp 8.374 to 8.857 UDL 0.521
Offspring age 233 bp/year 226 to 240 310 (221) 0.036
Genderb 2287 bp 2720 to 147 0.195 0.001
G–OA inter.c 10 bp/year 0.4 to 19 0.040 0.002
Paternal age 17 bp/year 13 to 22 2  10 (215) 0.026
aPartial eta squared values.
bAmount by which TL is larger in women compared with men.
cAmount by which cross sectionally estimated telomere attrition rate is
slower in women compared with men.
CI, confidence interval; UDL, under detection limit; G–OA inter.,
gender–offspring age interaction term.
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than the estimate of Unryn et al., 22 bp/year, although this
difference might be easily attributed to their relatively small
population size. On the other hand, 17 bp/year is substantially
higher than the observations of Njajou et al. (10), where 10 bp/
year was noted in an Amish population of ~900 subjects. The
origin of this discrepancy is unclear, and might perhaps be
attributed to the different methodology (quantitative PCR) or
population-dependent differences. However, if telomere
elongation in sperm cells is the sole cause of the paternal
age effect, large population-dependent differences are not
immediately to be expected.
The interaction between inheritance and paternal age at con-
ception is rather peculiar: although not genetically determined
in the father, paternal age at conception is marked in the off-
spring’s genetic background and will be further transmitted
genetically. Unryn et al. (17) already mentioned that the
cumulative impact of paternal inheritance throughout gener-
ations might explain a crucial part of inherited variation in
TL. Our results indeed show that paternal age at conception
should be seen as one of the major factors involved in TL vari-
ation explained by inheritance. International differences in
paternal age and associated demographic tendencies could
then also cause differences in basic TL between populations.
Further research is however necessary to assess the precise
cumulative impact.
We demonstrated that even within the small age range of the
Asklepios study (~35–55 years), shifts in paternal age affect
the cross-sectional estimates of telomere attrition rates. Over
larger time-frames, demographic tendencies even vary more
largely. For example, in East-Flanders, the Belgian province
in which the study area is located, an almost linear increase
in paternal age was observed during the period 1980–1997.
This contrasts with the decrease in paternal age of the Askle-
pios study from the immediate post-war period (1947) to the
baby boom generation of the sixties (until 1967) (32). It is
incontestable that in other countries and populations these
trends will differ. It is also to be expected that, when paternal
age varies non-linearly across generations, the cross section-
ally derived telomere attrition rate estimates will be affected
differently, making it very difficult to compare them between
different offspring age groups within the same study. Similar
problems are to be expected when comparing these estimates
between different studies.
Several diseases and socio-economical features have been
associated with parental age (33–35), on the other hand,
results from several studies have put forward TL as a marker
for biological aging and associated diseases (36). Since
paternal age is correlated with TL, confounding effects might
occur, indirectly resulting in, or obscuring, an association
between TL and these parental age determined traits.
Additionally, due to the substantial demographic evolution
of parental age throughout several generations co-evolving fea-
tures might also be incorrectly associated with TL. Therefore,
in future studies, adjustment for paternal age should be con-
sidered, particularly when the study encompasses subsequent
generations. For the Asklepios study population, which
covers a rather small age-range, our previously reported con-
clusions remained valid after adjustment for paternal age (22).
Figure 2. Longer telomeres (adjusted for age) in children of older fathers, independent of gender (men, filled squares, M; women, open circles, F).
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Alternatively, since several studies pointed out the effect of
oxidative stress and inflammation on TL (20,21,23,37), also
the telomere attrition rate could be used as aging biomarker.
However, large-scale longitudinal studies are necessary for a
precise estimate of this telomere attrition rate and its potential
biomarker value. This assessment is one of the major aims of
the follow-up rounds of the Asklepios longitudinal study.
In conclusion, we were able to show that paternal age at
birth is an important determinant of TL, explaining interindi-
vidual TL variance to a larger extent, a factor of 2, than
gender. These findings have important consequences on the
heritability of TL and the interpretation and comparability of
epidemiological TL studies.
MATERIALS AND METHODS
The Asklepios study methods and subjects were described
recently (27). DNA was isolated from whole blood EDTA,
maximally three days after blood sampling, using the Pure-
gene Genomic Purification Kit (Gentra Systems, Minnesota,
USA). Samples were long-termed stored at 2808C and ali-
quots of 5 mg were temporarily stored at 2208C for the TL
analysis. TLs were determined using the standard telomere
restriction fragment methodology with some in-house modifi-
cations and while blinded for the subjects IDs, as described
previously (27,38). In the original Asklepios study population
of 2524 subjects, reliable TL values were obtained for 2509
subjects (22). Since several volunteers were unable to
provide a paternal age at birth, the population currently
under study was further reduced to a total of 2433, consisting
of 1176 men and 1257 women. For the large majority of this
set (N ¼ 2281), TL measurements were available in duplicate
and averaged. In the reported subset, maternal age at birth
could be provided by all women and all but five men. When
paternal, maternal or parental age is mentioned, the age at
birth of the offspring is meant.
The ethical committee of the Ghent University Hospital
approved the study protocol and a written informed consent
was obtained from each participant prior to enrollment into
the study.
The statistical analysis was performed in SPSS, version
14.0.2. Standard Pearson correlation was used to estimate
the linear association between two variables. To estimate the
common effect of several variables, we constructed GLMs
containing an offspring age-adjustment (age as covariate)
and TL as dependent variable.
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